1)For the thiobarbituric acid test, a test solution containing free or acetylated sulfadiazine was diluted to the optimum concentration, 0.5 to 8. 0 mg per 100 ml, and adjusted to the optimum pH, about 1. 5, with I N hydrochloric acid buffer solution and a thiobarbituric acid solution. It is then heated in a boiling water bath for at least an hour, cooled at room temperature and its volume corrected. After centrifugation and between 30 and 60 mniutes after heating, calorimetric measurements of the solution were made with a photoelectric colorimter, using the 530 filter. The minimum concentation for accurate measurements was about 0.02 mg per 100 ml.
2) In the clinical blood sam ples, sera were used us testing materials and the proteins were precipitated with the same volumes of 15% trichloracetic acid.
3) In the clinical urine samples, urobilin, urobilinogen, bilirubin and acetone would formate color with thiobarbituric acid, but the normal urine, even in the presence of oxydation of pyridine group, did not interfere with the color imetric measurements.
4) Th e total blood concentration of sulfadiazine orally administered in combination with sulfamerazinc, isoxazine or marbadal showed certain patterns of fluctuation. These patterns were probably related to the difference in solubilities between sulfadiazine and the other component. The greater. the difference in solubilities, the greater was its effect upon the absorption of sulfadia zine. So, the mutual effect on absorption and excretion of orally administered sulfonamide mixture could best be observed in oral administration of sulfadiazine with isoxazine because of their greater solubility difference.
5) The blood level of sulfadiazine administered with isoxazine might take longer but not shorter, to reach its maximum than when administered alone. Several types of blood levels of sulfadiazine are produced according to the time required to reach its maximum blood level and the total amount absorbed.
6) Isoxazine, which is more soluble and more readily absorbed than sulfadiazine, showed no significant changes on combined administration with sulfadiazine in the time required to reach its maximum blood level, but coinciding with the maximum blood level of sulfadiazine, it showed a definite in its blood concentration and it remained lower than when administered alone.
7) In excretion, no significant differenc e could be found whether administered alone or in combination.
8) Desirable combination of sulfonamides for clinical application were discussed, based on the foregoing findings.
View full abstract